Kala Bio (KALA) Operating Margin (QoQ) (2019 - 2022)
Kala Bio (KALA) Operating Margin (QoQ) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - |
| 10 | Kala Bio | 9.88 Mn | 9.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -223,205.00 |
| Jun 30, 2022 | 101,645.00 |
| Mar 31, 2022 | 26,915.00 |
| Dec 31, 2021 | -167,231.00 |
| Sep 30, 2021 | 10,193.00 |
| Jun 30, 2021 | -8,505.00 |
| Mar 31, 2021 | 42,815.00 |
| Dec 31, 2020 | -13,103.00 |
| Sep 30, 2020 | 139,057.00 |
| Jun 30, 2020 | -67,554.00 |
| Mar 31, 2020 | -16,747.00 |
| Dec 31, 2019 | -22,526.00 |
| Sep 30, 2019 | -39,690.00 |
| Jun 30, 2019 | 64,576.00 |